The Use of the Biomaterial Collections Fund “NeuroResource” to Solve Fundamental and Applied Problems in Neurology and Psychiatry

Modern advances in genomics, proteomics, and cell technologies have opened up new opportunities for studying the pathophysiological foundations of mental and neurological disorders. A key element for such research is well-characterized biomaterial collections associated with detailed clinical data. The creation of such resources allows for the advancement of personalized medicine, including the search for biomarkers for diagnostics, prognosis, and treatment efficacy. In this paper, we present the experience of creating and using the Biomaterial Collections Fund “NeuroResource” registered at the Mental Health Research Center.